SCHEMBL20204791

SCHEMBL20204791

C/C=C(/C)C(=N)c1c[nH]c2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.57
GPR84 Q9NQS5 1/20 0.51
NR4A2 P43354 2/20 0.49
CREBBP Q92793 1/20 0.49
ALDH1A1 P00352 2/20 0.49
ATM Q13315 2/20 0.49
LMNA P02545 1/20 0.47
KMT2A Q03164 2/20 0.46
MAPK1 P28482 1/20 0.45
IDO1 P14902 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAOB P27338 1/20 0.43
MEN1 O00255 1/20 0.43
CTNNB1 P35222 1/20 0.43
WNT3A P56704 1/20 0.43
ADAM17 P78536 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20204839 0.82 PBRM1 (0.51) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL21246198 0.80 PBRM1 (0.67) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL4029828 0.80 PBRM1 (0.67) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL20204958 0.80 PBRM1 (0.57) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL4029825 0.80 PBRM1 (0.67) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL7372877 0.76 PBRM1 (0.71) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL17232878 0.76 PBRM1 (0.71) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL23773692 0.74 ALDH1A1 (0.54) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL6156793 0.74 PBRM1 (0.58) PBRM1GPR84NR4A2CREBBPALDH1A1
SCHEMBL50742 0.73 PBRM1 (1.00) PBRM1GPR84NR4A2CREBBPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098473-A1 REAGENTS AND METHODS FOR ANALYSIS OF PROTEINS AND METABOLITES TARGETED BY COVALENT PROBES DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-05-31 WO disclosed